• Explore /
  • Poster
  • / A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

Abstract Poster

Authors

null

Jennifer Rachel Eads

University of Pennsylvania, Philadelphia, PA

Jennifer Rachel Eads , Michelle Weitz , Michael K. Gibson , Lakshmi Rajdev , Onkar V Khullar , Steven H. Lin , Constantine Gatsonis , Ignacio Ivan Wistuba , Aravind Sanjeevaiah , Al Bowen Benson III, Nathan Bahary , Kristen Renee Spencer , Nabil F. Saba , Stanley R. Hamilton , Charles A. Staley , Anuradha Bapsi Chakravarthy , Terence Z. Wong , Peter J. O'Dwyer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT03604991

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS4651)

DOI

10.1200/JCO.2020.38.15_suppl.TPS4651

Abstract #

TPS4651

Poster Bd #

259

Abstract Disclosures

Similar Posters

First Author: Jennifer Rachel Eads

First Author: Minke W. Lucas

First Author: Patrick M. Forde

First Author: Judith M. Versluis